The JFS Wealth Advisors LLC Has $2,041,000 Stake in CVS Health Corporation (CVS)

The JFS Wealth Advisors LLC Has $2,041,000 Stake in CVS Health Corporation (CVS)

JFS Wealth Advisors LLC boosted its position in CVS Health Corporation (NYSE:CVS) by 20.1% during the third quarter, Holdings Channel reports. The fund owned 22,933 shares of the pharmacy operator’s stock after buying an additional 3,835 shares during the period. JFS Wealth Advisors LLC’s holdings in CVS Health Corporation were worth $2,041,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Torch Wealth Management LLC bought a new position in shares of CVS Health Corporation during the second quarter worth about $1,130,000. YHB Investment Advisors Inc. boosted its position in shares of CVS Health Corporation by 5.6% in the second quarter. YHB Investment Advisors Inc. now owns 93,368 shares of the pharmacy operator’s stock worth $8,939,000 after buying an additional 4,926 shares during the period. Winslow Evans & Crocker Inc. boosted its position in shares of CVS Health Corporation by 23.6% in the second quarter. Winslow Evans & Crocker Inc. now owns 19,308 shares of the pharmacy operator’s stock worth $1,849,000 after buying an additional 3,684 shares during the period. Hermes Investment Management Ltd. boosted its position in shares of CVS Health Corporation by 8.4% in the second quarter. Hermes Investment Management Ltd. now owns 783,901 shares of the pharmacy operator’s stock worth $75,051,000 after buying an additional 61,000 shares during the period. Finally, DORCHESTER WEALTH MANAGEMENT Co boosted its position in shares of CVS Health Corporation by 4.0% in the second quarter. DORCHESTER WEALTH MANAGEMENT Co now owns 60,135 shares of the pharmacy operator’s stock worth $5,757,000 after buying an additional 2,335 shares during the period. Hedge funds and other institutional investors own 80.32% of the company’s stock.

Shares of CVS Health Corporation (NYSE:CVS) traded down 0.41% on Thursday, reaching $83.20. The company’s stock had a trading volume of 5,220,496 shares. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $106.67. The stock has a market cap of $88.73 billion, a P/E ratio of 17.83 and a beta of 0.84. The firm’s 50 day moving average is $80.03 and its 200-day moving average is $87.20.

CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings results on Tuesday, November 8th. The pharmacy operator reported $1.64 EPS for the quarter, topping the Zacks’ consensus estimate of $1.57 by $0.07. The business had revenue of $44.60 billion for the quarter, compared to analyst estimates of $45.29 billion. CVS Health Corporation had a return on equity of 17.18% and a net margin of 2.96%. CVS Health Corporation’s quarterly revenue was up 15.5% compared to the same quarter last year. During the same period last year, the company posted $1.28 earnings per share. On average, equities research analysts forecast that CVS Health Corporation will post $5.81 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, February 2nd. Investors of record on Tuesday, January 24th will be issued a dividend of $0.50 per share. This is a positive change from CVS Health Corporation’s previous quarterly dividend of $0.43. This represents a $2.00 dividend on an annualized basis and a yield of 2.40%. The ex-dividend date of this dividend is Friday, January 20th. CVS Health Corporation’s dividend payout ratio (DPR) is 36.40%.

Several equities analysts have recently weighed in on CVS shares. Robert W. Baird cut their price objective on CVS Health Corporation from $114.00 to $104.00 and set an “outperform” rating on the stock in a report on Monday, October 3rd. Leerink Swann reiterated an “outperform” rating and set a $105.00 price objective (down previously from $110.00) on shares of CVS Health Corporation in a report on Sunday, October 2nd. Mizuho reiterated a “buy” rating and set a $111.00 price objective on shares of CVS Health Corporation in a report on Friday, September 30th. Vetr upgraded CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $98.36 price objective on the stock in a report on Monday, October 24th. Finally, Credit Suisse Group AG reiterated an “outperform” rating and set a $110.00 price objective (down previously from $115.00) on shares of CVS Health Corporation in a report on Tuesday, October 4th. Seven equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $101.77.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Related posts

Leave a Comment